Clinical Trial Update: A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist [Phase 4]

View source ↗

Summary

Phase 4 trial update studying gastrointestinal emptying time in adults with migraine before and after starting a CGRP monoclonal antibody antagonist.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2022-03-22